Clinical Relevance of the Serial Measurement of Krebs von den Lungen-6 Levels in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease.

Shirai, Yuichiro; Fukue, Ryosuke; Kaneko, Yuko; Kuwana, Masataka

Shirai, Yuichiro; Fukue, Ryosuke; Kaneko, Yuko; Kuwana, Masataka.

Afiliación

Shirai Y; Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo 113-8603, Japan.
Fukue R; Scleroderma/Myositis Center of Excellence, Nippon Medical School Hospital, Tokyo 113-8603, Japan.
Kaneko Y; Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo 113-8603, Japan.
Kuwana M; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo 160-8582, Japan.

Diagnostics (Basel) ; 11(11)2021 Oct 28.

Article en En | MEDLINE | ID: mdl-34829353

Palabras clave

biomarker; immunomodulatory treatment; interstitial lung disease; pneumoprotein; scleroderma; systemic sclerosis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Diagnostics (Basel) Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google